CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. TOP PLAYER POSITIONING, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Increasing demand for minimally invasive reconstruction surgeries
3.4.1.2. Technological advancement
3.4.1.3. Congenital face and tooth deformities
3.4.1.4. Awareness about aesthetics appearance

3.4.2. Restraints

3.4.2.1. High cost of treatment and low reimbursements
3.4.2.2. Risk of malfunctions

3.4.3. Opportunities

3.4.3.1. Preference for a better quality of life and increasing medical tourism
3.4.3.2. Adoption of cosmetic implants to enhance aesthetic looks

3.4.4. Impact analysis

CHAPTER 4 GLOBAL MEDICAL AESTHETIC DEVICES MARKET BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. DEVICES

4.2.1. Key market trends
4.2.2. Key growth factors & opportunities
4.2.3. Market size and forecast
4.2.4. Aesthetic laser

4.2.4.1. Ablative lasers
4.2.4.2 Market size and forecast
4.2.4.3. Non-ablative lasers
4.2.4.4 Market size and forecast

4.2.5. Skin tightening and body contouring devices

4.2.5.1. Liposuction devices
4.2.5.2. Market size and forecast
4.2.5.3. Skin tightening devices
4.2.5.4. Market size and forecast
4.2.5.5. Cellulite reduction devices
4.2.5.6. Market size and forecast

4.3. AESTHETIC IMPLANTS

4.3.1. Key market trends
4.3.2. Key growth factors & opportunities
4.3.3. Market size and forecast
4.3.4. Dental implants

4.3.4.1. Root form dental implants
4.3.4.2. Market size and forecast
4.3.4.3. Plate form dental implants
4.3.4.4. Market size and forecast

4.3.5. Breast implants

4.3.5.1. Saline filled
4.3.5.2. Market size and forecast
4.3.5.3. Silicone gel filled
4.3.5.4. Market size and forecast

4.3.6. Facial implants

4.3.6.1 Market size and forecast

4.3.7. Other implants

4.3.7.1 Market size and forecast

CHAPTER 5 GLOBAL MEDICAL AESTHETIC DEVICES MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. SURGICAL

5.2.1 Face & Head

5.2.1.1. Brow Lift
5.2.1.2. Market size and forecast
5.2.1.3. Ear Surgery
5.2.1.4. Market size and forecast
5.2.1.5. Eyelid Surgery
5.2.1.6. Market size and forecast
5.2.1.7. Facial Bone Contouring
5.2.1.8. Market size and forecast
5.2.1.9. Facial Fat Grafting
5.2.1.10. Market size and forecast
5.2.1.11. Eyelid Surgery
5.2.1.12. Market size and forecast
5.2.1.13. Facial Bone Contouring
5.2.1.14. Market size and forecast
5.2.1.15. Facial Fat Grafting
5.2.1.16. Market size and forecast

5.2.2 Breast

5.2.2.1. Breast Augmentation
5.2.2.2. Market size and forecast
5.2.2.3. Breast Lift
5.2.2.4. Market size and forecast

5.2.3 Body & Extremities

5.2.3.1. Abdominoplasty
5.2.3.2. Market size and forecast
5.2.3.3. Buttock Augmentation
5.2.3.4. Market size and forecast
5.2.3.5. Buttock Lift
5.2.3.6. Market size and forecast
5.2.3.7. Liposuction
5.2.3.8. Market size and forecast
5.2.3.9. Lower Body Lift
5.2.3.10. Market size and forecast
5.2.3.11. Penile Enlargement
5.2.3.12. Market size and forecast
5.2.3.13. Thigh Lift
5.2.3.14. Market size and forecast
5.2.3.15. Upper Arm Lift
5.2.3.16. Market size and forecast
5.2.3.17. Upper Body Lift
5.2.3.18. Market size and forecast
5.2.3.19. Labiaplasty
5.2.3.20. Market size and forecast
5.2.3.21. Vaginal Rejuvenation
5.2.3.22. Market size and forecast

5.2. Non-Surgical

5.2.1 Market size and forecast

CHAPTER 6 GLOBAL MEDICAL AESTHETIC DEVICES MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS & CLINICS

6.2.1. Market size and forecast

6.3. MEDICAL SPAS & BEAUTY CENTERS

6.3.1. Market size and forecast

CHAPTER 7 GLOBAL MEDICAL AESTHETIC DEVICES MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S.
7.2.5. Canada
7.2.6. Mexico

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany
7.3.5. France
7.3.6. UK
7.3.7. Italy
7.3.8. Spain
7.3.9. Rest of Europe

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan
7.4.5. China
7.4.6. India
7.4.7. South Korea
7.4.8. Australia
7.4.9. Rest of Asia-Pacific

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil
7.5.5. South Africa
7.5.6. Saudi Arabia
7.5.7. Rest of LAMEA

CHAPTER 8 COMPANY PROFILES

8.1. ALLERGAN PLC

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves & developments

8.2. SOLTA MEDICAL INC. (A DIVISION OF VALEANT PHARMACEUTICALS INTERNATIONAL INC.)

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves & developments

8.3. SYNERON MEDICAL LTD.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves & developments

8.4. CYNOSURE INC. (A DIVISION OF HOLOGIC, INC.)

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves & developments

8.5. LUMENIS LTD.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves & developments

8.6. JOHNSON & JOHNSON

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves & developments

8.7. MERZ PHARMA GMBH & CO. KGAA

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves & developments

8.8. ALMA LASERS LTD. (ACQUIRED BY SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO. LTD.)

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves & developments

8.9. GC AESTHETICS PLC

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves & developments

8.10. SIENTRA INC.

8. 10.1. Company overview
8. 10.2. Company snapshot
8. 10.3. Operating business segments
8. 10.4. Business performance
8. 10.5. Key strategic moves & developments

8.11. ZIMMER BIOMET HOLDINGS, INC.

8. 11.1. Company overview
8. 11.2. Company snapshot
8. 11.3. Operating business segments
8. 11.4. Business performance
8. 11.5. Key strategic moves & developments

8.12. DENTSPLY SIRONA INC.

8. 12.1. Company overview
8. 12.2. Company snapshot
8. 12.3. Operating business segments
8. 12.4. Business performance
8. 12.5. Key strategic moves & developments